Biophysicochemical Interaction of a Clinical Pulmonary Surfactant with Nanoalumina

Langmuir. 2015 Jul 7;31(26):7346-54. doi: 10.1021/acs.langmuir.5b01639. Epub 2015 Jun 25.

Abstract

We report on the interaction of pulmonary surfactant composed of phospholipids and proteins with nanometric alumina (Al2O3) in the context of lung exposure and nanotoxicity. We study the bulk properties of phospholipid/nanoparticle dispersions and determine the nature of their interactions. The clinical surfactant Curosurf, both native and extruded, and a protein-free surfactant are investigated. The phase behavior of mixed surfactant/particle dispersions was determined by optical and electron microscopy, light scattering, and zeta potential measurements. It exhibits broad similarities with that of strongly interacting nanosystems such as polymers, proteins or particles, and supports the hypothesis of electrostatic complexation. At a critical stoichiometry, micron-sized aggregates arising from the association between oppositely charged vesicles and nanoparticles are formed. Contrary to the models of lipoprotein corona or of particle wrapping, our work shows that vesicles maintain their structural integrity and trap the particles at their surfaces. The agglomeration of particles in surfactant phase is a phenomenon of importance that could change the interactions of the particles with lung cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aluminum Oxide / chemistry*
  • Chemical Phenomena*
  • Hydrogen-Ion Concentration
  • Nanoparticles / chemistry*
  • Phospholipids / chemistry
  • Pulmonary Surfactants / chemistry*
  • Static Electricity
  • Surface Properties
  • Time Factors

Substances

  • Phospholipids
  • Pulmonary Surfactants
  • Aluminum Oxide